in

Office of Inspector General Investigating FDA's Accelerated Approvals – UncoverDC

The FDA’s accelerated approval of an Alzheimer drug is under investigation, with 3 advisory panel members quitting following the approval.

This post was created with our nice and easy submission form. Create your post!

Comments

Loading…

Posted by GigiBowman

Chevy Warns: Park Our EVs 50 Feet From Nearest Vehicle

FDA Panel Votes 16-2 Against COVID Booster Shots Except for Those Over 65 and … – Granite Grok